Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M46,629Revenue $M6,219Net Margin (%)51.7Altman Z-Score4.7
Enterprise Value $M48,869EPS $16.4Operating Margin %26.6Piotroski F-Score6
P/E(ttm)14.4Beneish M-Score-3.0Pre-tax Margin (%)52.5Higher ROA y-yY
Price/Book5.210-y EBITDA Growth Rate %--Quick Ratio0.4Cash flow > EarningsY
Price/Sales7.45-y EBITDA Growth Rate %27.4Current Ratio0.6Lower Leverage y-yY
Price/Free Cash Flow13.3y-y EBITDA Growth Rate %73.1ROA % (ttm)22.8Higher Current Ratio y-yN
Dividend Yield %0.3PEG0.5ROE % (ttm)41.2Less Shares Outstanding y-yN
Payout Ratio %4.0Shares Outstanding M200ROIC % (ttm)18.1Gross Margin Increase y-yY

Gurus Latest Trades with SHPG

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
SHPGJohn Paulson 2015-06-30 Reduce-1.55%$226.9 - $260.15
($247.87)
$ 232.96-6%Reduce 14.81%7,095,100
SHPGFirst Eagle Investment 2015-06-30 Reduce-0.17%$226.9 - $260.15
($247.87)
$ 232.96-6%Reduce 98.36%4,830
SHPGLeon Cooperman 2015-06-30 Reduce-0.02%$226.9 - $260.15
($247.87)
$ 232.96-6%Reduce 0.80%496,192
SHPGKen Fisher 2015-06-30 Add$226.9 - $260.15
($247.87)
$ 232.96-6%Add 36.31%20,161
SHPGFirst Eagle Investment 2015-03-31 Add0.12%$205.66 - $253.64
($229.81)
$ 232.961%Add 254.93%294,539
SHPGLeon Cooperman 2015-03-31 Add0.1%$205.66 - $253.64
($229.81)
$ 232.961%Add 5.70%500,192
SHPGMario Gabelli 2015-03-31 Sold Out -0.018%$205.66 - $253.64
($229.81)
$ 232.961%Sold Out0
SHPGKen Fisher 2015-03-31 Add$205.66 - $253.64
($229.81)
$ 232.961%Add 1.35%14,791
SHPGLeon Cooperman 2014-12-31 Buy 1.7%$170.49 - $262.71
($211.39)
$ 232.9610%New holding473,237
SHPGJohn Paulson 2014-12-31 Reduce-0.77%$170.49 - $262.71
($211.41)
$ 232.9610%Reduce 7.93%8,328,304
SHPGDavid Tepper 2014-12-31 Sold Out -0.71%$170.49 - $262.71
($211.58)
$ 232.9610%Sold Out0
SHPGFirst Eagle Investment 2014-12-31 Add0.04%$170.49 - $262.71
($211.58)
$ 232.9610%Add 453.24%82,986
SHPGMario Gabelli 2014-12-31 Reduce-0.03%$170.49 - $262.71
($211.58)
$ 232.9610%Reduce 57.13%16,225
SHPGKen Fisher 2014-12-31 Add0.01%$170.49 - $262.71
($211.58)
$ 232.9610%Add 416.24%14,594
SHPGJohn Paulson 2014-09-30 Add6.09%$231.98 - $262.64
($248.14)
$ 232.96-6%Add 168.70%9,046,000
SHPGDavid Tepper 2014-09-30 Buy 0.71%$231.98 - $262.64
($248.14)
$ 232.96-6%New holding185,944
SHPGMario Gabelli 2014-09-30 Buy 0.05%$231.98 - $262.64
($248.14)
$ 232.96-6%New holding37,850
SHPGFirst Eagle Investment 2014-09-30 Buy 0.01%$231.98 - $262.64
($248.14)
$ 232.96-6%New holding15,000
SHPGKen Fisher 2014-09-30 Reduce$231.98 - $262.64
($248.14)
$ 232.96-6%Reduce 39.56%2,827
SHPGJohn Paulson 2014-06-30 Add0.84%$142.83 - $234.98
($172.9)
$ 232.9635%Add 33.07%3,366,539
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

SHPG is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


SHPG: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Quarterly/Annual Reports about SHPG:

    News about SHPG:

    Articles On GuruFocus.com
    Undervalued Baxalta Shares Target of Acquisition by Shire Plc Aug 05 2015 
    Manning & Napier's Top 5 New Stock Buys of Q2 Jul 09 2015 
    Manning & Napier Invests in Stake in Baidu Jul 08 2015 
    Invesco European Growth Fund Parts With Two Stakes Jul 01 2015 
    Andreas Halvorsen Increases Stake in Esperion Therapeutics Jun 29 2015 
    Smart Guru John Paulson Bullish on Actavis Jun 18 2015 
    8 Top Healthcare Stocks to Watch May 13 2015 
    John Paulson's Stocks Trading at Low P/E May 04 2015 
    Shire Reports A Good Quarter Promoted By Drug Sales May 03 2015 
    Top Stock Picks Among Companies That Recently Increased Dividends Mar 09 2015 

    More From Other Websites
    Shire Inks Deal with Sanquin to Expand Cinryze Production Aug 26 2015
    Could SkyePharma PLC Outperform Shire PLC And Hikma Pharmaceuticals Plc? Aug 26 2015
    Could SkyePharma PLC Outperform Shire PLC And Hikma Pharmaceuticals Plc? Aug 26 2015
    Shire Falls but Mylan’s Rise Boosts Large-Cap IBB Pharma Subgroup Aug 25 2015
    7:01 am Shire plc enters into an agreement with Sanquin Blood Supply, providing Shire access to its... Aug 25 2015
    Shire to Attain Enhanced CINRYZE® Manufacturing Flexibility and Capacity Aug 25 2015
    SHIRE PLC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Aug 24 2015
    IBB Outperforms XBI: Top 10 Large-Cap Stocks Aug 20 2015
    Billionaire Paulson’s Top Healthcare Picks Include Allergan PLC (AGN), Valeant Pharmaceuticals... Aug 20 2015
    Regeneron Leads and Shire Dragged the Large-Cap Stocks Aug 19 2015
    Benzinga's M&A Chatter for Tuesday August 18, 2015 Aug 18 2015
    John Paulson Betting On Healthcare And Consumer Discretionary Stocks Aug 18 2015
    Britain's FTSE falters as commodity stocks crumple Aug 18 2015
    Britain's FTSE falters as commodity stocks crumple Aug 18 2015
    Britain's FTSE falters as commodity stocks crumple Aug 18 2015
    Britain's FTSE falters as commodity stocks crumple Aug 18 2015
    Britain's FTSE falters as commodity stocks crumple Aug 18 2015
    Who Should Allergan Buy? Aug 17 2015
    Is It Time To Buy John Wood Group PLC, WM Morrison Supermarkets plc & Shire plc? Aug 17 2015
    Orphan drugs are popular targets Aug 16 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK